UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Cancers, 2023-01, Vol.15 (2), p.391

2023

Link zum Volltext

Verfügbarkeit prüfen

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Journal of clinical epidemiology, 2020-03, Vol.119, p.7-18

2020

Link zum Volltext

Verfügbarkeit prüfen

Poor performance of clinical prediction models: the harm of commonly applied methods

Journal of clinical epidemiology, 2018-06, Vol.98, p.133-143

2018

Link zum Volltext

Verfügbarkeit prüfen

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Genetics in medicine, 2022-06, Vol.24 (6), p.1196-1205

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1579-1579

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.678-678

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.19112-19125

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1517-1517

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1521-1521

2016

Link zum Volltext

Verfügbarkeit prüfen

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS779-TPS779

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1512-1512

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1501-1501

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4272-4272

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Clinical gastroenterology and hepatology, 2013-12, Vol.12 (6), p.1046-1050

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1530-1530

2013

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2165-2172

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Clinical gastroenterology and hepatology, 2020-04, Vol.18 (4), p.830-837.e1

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential

British journal of cancer, 2022-06, Vol.126 (11), p.1595-1603

2022

Link zum Volltext

Verfügbarkeit prüfen

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1221-S-1222

2024

Link zum Volltext

Verfügbarkeit prüfen

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10503-10503

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4083-4094

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4086-4094

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals

Familial cancer, 2021-04, Vol.20 (2), p.111-116

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10523-10523

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(12)
Oncology
(11)
Colorectal Cancer
(8)
Colorectal Neoplasms, Hereditary Nonpolyposis - Genetics
(7)
Female
(7)
Genetic Disorders
(6)
Male
(6)
Epidemiology
(5)
Family Medical History
(5)
Genetic Testing
(5)
Genetics & Heredity
(5)
Cohort Studies
(4)
Colorectal Carcinoma
(4)
Genetic Counseling
(4)
Lynch Syndrome
(4)
Microsatellite Instability
(4)
Middle Aged
(4)
Mutation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

Changing predictor measurement procedures affected the performance of prediction models in clinical examples

Poor performance of clinical prediction models: the harm of commonly applied methods

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts)

Identification of Lynch syndrome (LS) in patients (pts) without prior LS-associated cancer

Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study

Implementing universal genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts)

Prevalence of germline cancer susceptibility gene mutations in a consecutive series of 799 colorectal cancer (CRC) patients (pts)

Abstract 4272: Mutations in RABL3 alter RAS prenylation and are associated with hereditary pancreatic cancer

Therapy-associated polyposis – a novel form of acquired gastrointestinal polyposis

Cancer risks and mutation spectrum of mismatch repair genes in African American families with Lynch syndrome

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome

Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential

Tu1018 A MIXED METHODS APPROACH TO ASSESSING BARRIERS AND FACILITATORS TO CANCER GENETICS CARE IN BLACK AND LATINO/A/X INDIVIDUALS AFFECTED BY PANCREATIC CANCER: THE RACIAL/ETHNIC GENETIC EDUATION, RISK ASSESSMENT, AND TESTING (REGENERATE) STUDY

Implementing systematized patient-facing Lynch syndrome (LS) risk assessment in oncology using the electronic health record (EHR) system

Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients

Aktive Filter

Suchergebnisse filtern